BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

708 related articles for article (PubMed ID: 25840008)

  • 21. POSCAbilities: The Application of the Prion Organotypic Slice Culture Assay to Neurodegenerative Disease Research.
    Pineau H; Sim V
    Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32698402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aβ seeds and prions: How close the fit?
    Rasmussen J; Jucker M; Walker LC
    Prion; 2017 Jul; 11(4):215-225. PubMed ID: 28657440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The expanding realm of prion phenomena in neurodegenerative disease.
    Frost B; Diamond MI
    Prion; 2009; 3(2):74-7. PubMed ID: 19448400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What Makes a Prion: Infectious Proteins From Animals to Yeast.
    MacLea KS
    Int Rev Cell Mol Biol; 2017; 329():227-276. PubMed ID: 28109329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Review: membrane-associated misfolded protein propagation in natural transmissible spongiform encephalopathies (TSEs), synthetic prion diseases and Alzheimer's disease.
    Jeffrey M
    Neuropathol Appl Neurobiol; 2013 Apr; 39(3):196-216. PubMed ID: 23171056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In Vitro Prion Amplification Methodology for Inhibitor Screening.
    Vieira TCRG; Silva JL
    Methods Mol Biol; 2019; 1873():305-316. PubMed ID: 30341619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic Changes in Prion and Prion-like Neurodegenerative Diseases: Recent Advances, Potential as Biomarkers, and Future Perspectives.
    Hernaiz A; Toivonen JM; Bolea R; Martín-Burriel I
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amyloid and prions: some biochemical investigations of cerebral amyloidosis in mice.
    Hope J; Kirby L
    Folia Neuropathol; 2012; 50(1):13-9. PubMed ID: 22505360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generalization of the prion hypothesis to other neurodegenerative diseases: an imperfect fit.
    Guest WC; Silverman JM; Pokrishevsky E; O'Neill MA; Grad LI; Cashman NR
    J Toxicol Environ Health A; 2011; 74(22-24):1433-59. PubMed ID: 22043906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amyloids, prions and the inherent infectious nature of misfolded protein aggregates.
    Soto C; Estrada L; Castilla J
    Trends Biochem Sci; 2006 Mar; 31(3):150-5. PubMed ID: 16473510
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Sandhof CA; Hoppe SO; Tittelmeier J; Nussbaum-Krammer C
    Biomolecules; 2020 Aug; 10(8):. PubMed ID: 32824215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of cellular prion protein in interneuronal amyloid transmission.
    Del Río JA; Ferrer I; Gavín R
    Prog Neurobiol; 2018; 165-167():87-102. PubMed ID: 29530723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prions and protein-folding diseases.
    Norrby E
    J Intern Med; 2011 Jul; 270(1):1-14. PubMed ID: 21481020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein misfolding and neurodegeneration.
    Soto C; Estrada LD
    Arch Neurol; 2008 Feb; 65(2):184-9. PubMed ID: 18268186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders.
    Jucker M; Walker LC
    Ann Neurol; 2011 Oct; 70(4):532-40. PubMed ID: 22028219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent progress in prion and prion-like protein aggregation.
    Yi CW; Xu WC; Chen J; Liang Y
    Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):520-6. PubMed ID: 23709368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein folding and aggregation: two sides of the same coin in the condensation of proteins revealed by pressure studies.
    Silva JL; Cordeiro Y; Foguel D
    Biochim Biophys Acta; 2006 Mar; 1764(3):443-51. PubMed ID: 16480935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The propagation of prion-like protein inclusions in neurodegenerative diseases.
    Goedert M; Clavaguera F; Tolnay M
    Trends Neurosci; 2010 Jul; 33(7):317-25. PubMed ID: 20493564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prion-like mechanisms in the pathogenesis of tauopathies and synucleinopathies.
    Goedert M; Falcon B; Clavaguera F; Tolnay M
    Curr Neurol Neurosci Rep; 2014 Nov; 14(11):495. PubMed ID: 25218483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Prion 2018 round tables (II): Aβ, tau, α-synuclein… are they prions, prion-like proteins, or what?
    Eraña H
    Prion; 2019 Jan; 13(1):41-45. PubMed ID: 30646820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.